title: False-positive Xpert(®) MTB/RIF assays and previous treatment.
authors: Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa. tomboyles@yahoo.com.
authors: Tom H
authors: TH
authors: Boyles
authors: Médecins Sans Frontières, Khayelitsha, South Africa.
authors: Jennifer
authors: J
authors: Hughes
authors: Médecins Sans Frontières, Khayelitsha, South Africa.
authors: Vivian
authors: V
authors: Cox
authors: Khayelitsha District Hospital, Khayelitsha, South Africa.
authors: Rosie
authors: R
authors: Burton
authors: Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
authors: Graeme
authors: G
authors: Meintjes
authors: Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa.
authors: Marc
authors: M
authors: Mendelson
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification*; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D012141:Respiratory Tract Infections / Q000175:diagnosis*; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000175:diagnosis*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D012293:Rifampin